APOE and Alzheimer disease: DNA methylation is associated with both genetic and environmental factors, and previous studies have identified associations with AD and neuropathological hallmarks of AD [10–12], AD risk factors (e.g. ageing [13], obesity [14] and lipid levels [15]), as well as modifiers of APOE genotype effects (e.g. sex [16] and ethnicity [17, 18]).